Sergio Raposeiras-Roubin

17PUBLICATIONS
156CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Occupational epidemiologyMedical infection agents (incl. prions)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Mar 16, 2026
Early Sodium-Glucose Cotransporter 2 Inhibitor Initiation During Hospitalisation: Viewpoint on the DAPA ACT HF-TIMI 68 Trial.

Hugo Prado-Prado, Sergio Raposeiras-Roubín

|Nov 07, 2025
Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempedACS Randomized Clinical Trial.

Sergio Raposeiras-Roubín, Emad Abu Assi, César Jiménez Méndez

|Sep 15, 2025
Effectiveness and Safety of Lumbar Erector Spinae Plane Block Versus No Locoregional Block in Hip Surgery: Protocol for a Randomized Controlled Trial.

Laura García-Reza, Sergio Raposeiras, Javier P Loureiro

|Dec 23, 2024
Prostatic amyloidosis: pathological features of an underdiagnosed condition.

José A Ortiz-Rey, Jorge Sánchez-Ramos, Samer Abdulkader-Sande

|Oct 27, 2024
Derivation and Validation of the PRECISE-HBR Score to Predict Bleeding After Percutaneous Coronary Intervention.

Felice Gragnano, David van Klaveren, Dik Heg

|Sep 18, 2024
Ramipril After Transcatheter Aortic Valve Implantation in Patients Without Reduced Ejection Fraction: The RASTAVI Randomized Clinical Trial.

Ignacio J Amat-Santos, Diego López-Otero, Luis Nombela-Franco

Pageof 3

Frequent Collaborators

4 joint publications

Ivan Javier Nuñez-Gil

4 joint publications

Aitor Uribarri

3 joint publications

Bernardo Cortese

3 joint publications

Francesco Santoro